APOE and Alzheimer disease: In regard to AD, SH-SY5Y cells can be modified to model some pathological aspects of the disease, such as neurodegeneration after exposure to Aβ oligomers [76], oxidative stress [77] and apoptosis [78], as well as to better understand the role of ApoE in AD [79].